EN
首页 资讯 期刊 导师 问答 求职 发Paper 文献直达 高级搜索 期刊列表
当前位置： X-MOL 学术 › Mol. Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
Molecular Cancer ( IF 27.7 ) Pub Date : 2024-10-18 , DOI: 10.1186/s12943-024-02158-w
Joshua E Allen, Gabriel Krigsfeld, Luv Patel, Patrick A Mayes, David T Dicker, Gen Sheng Wu, Wafik S El-Deiry

Correction: Mol Cancer 14, 99 (2015)

https://doi.org/10.1186/s12943-015-0346-9


Following publication of the original article [1], the authors reported inadvertent errors in two panels of Figure 3.

The original Figure 3B shows a duplication of a histological image. The duplicated image has been replaced and the images, as well as their labels, have been accurately arranged in the corrected Figure 3. In addition, the attached corrected Figure 3 revises two time point labels in panel E.

The following clarification was added to figure legend 3E: “A portion of the control and ONC201/TIC10 results shown for reference were previously published [26].” The corrected and incorrect figures are given below.

Incorrect Figure 3:

figure a

Correct Figure 3:

figure b

  1. Allen JE, Krigsfeld G, Patel L, et al. Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway. Mol Cancer. 2015;14:99. https://doi.org/10.1186/s12943-015-0346-9.

    Article PubMed PubMed Central Google Scholar

Download references

Authors and Affiliations

  1. Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA

    Joshua E Allen, Gabriel Krigsfeld, Luv Patel, Patrick A Mayes, David T Dicker & Wafik S El-Deiry

  2. Current affiliation: Oncoceutics, Inc., Hummelstown, PA, USA

    Joshua E Allen

  3. Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, 19111, PA, USA

    David T Dicker & Wafik S El-Deiry

  4. Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Gen Sheng Wu

Authors
  1. Joshua E AllenView author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriel KrigsfeldView author publications

    You can also search for this author in PubMed Google Scholar

  3. Luv PatelView author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick A MayesView author publications

    You can also search for this author in PubMed Google Scholar

  5. David T DickerView author publications

    You can also search for this author in PubMed Google Scholar

  6. Gen Sheng WuView author publications

    You can also search for this author in PubMed Google Scholar

  7. Wafik S El-DeiryView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wafik S El-Deiry.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allen, J.E., Krigsfeld, G., Patel, L. et al. Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway. Mol Cancer 23, 233 (2024). https://doi.org/10.1186/s12943-024-02158-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12943-024-02158-w

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative



中文翻译：

更正：TRAIL 诱导化合物的鉴定突出了小分子 ONC201/TIC10 作为激活 TRAIL 通路的独特抗癌剂


更正：Mol Cancer 14， 99 （2015）

https://doi.org/10.1186/s12943-015-0346-9



在原始文章 [1] 发表后，作者报告了图 3 的两个面板中的无意错误。


原始图 3B 显示了组织学图像的复制。复制的图像已被替换，并且图像及其标签已准确排列在校正后的图 3 中。此外，随附的校正图 3 修改了面板 E 中的两个时间点标签。


图例 3E 中添加了以下说明：“部分对照和 ONC201/TIC10 结果仅供参考，之前已发表 [26]。更正和不正确的数字如下。

 不正确的图 3：

figure a

 正确的图 3：

figure b


  1. 文章： PubMed PubMed Central Google Scholar

 下载参考资料

 作者和单位


  1. 宾夕法尼亚大学医学院医学、遗传学和药理学系，分子肿瘤学和细胞周期调控实验室，美国费城，19104


    Joshua E Allen， Gabriel Krigsfeld， Luv Patel， Patrick A Mayes， David T Dicker & Wafik S El-Deiry


  2. 当前隶属关系： Oncoceutics， Inc.， Hummelstown， PA， USA

     约书亚·艾伦


  3. 美国宾夕法尼亚州费城 Fox Chase 癌症中心肿瘤内科和分子治疗学项目、转化肿瘤学和实验癌症治疗学实验室

    David T Dicker & Wafik S El-Deiry


  4. 韦恩州立大学医学院卡马诺斯癌症研究所病理学系，分子生物学和遗传学项目，美国密歇根州底特律 48201，美国

    Gen Sheng Wu

 作者

  1. 约书亚·艾伦查看作者出版物


    您也可以在 PubMed Google Scholar 中搜索此作者


  2. 加布里埃尔·克里格斯菲尔德查看作者出版物


    您也可以在 PubMed Google Scholar 中搜索此作者


  3. 卢夫·帕特尔查看作者出版物


    您也可以在 PubMed Google Scholar 中搜索此作者


  4. 帕特里克·梅斯查看作者出版物


    您也可以在 PubMed Google Scholar 中搜索此作者


  5. 大卫·迪克查看作者出版物


    您也可以在 PubMed Google Scholar 中搜索此作者


  6. Gen Sheng Wu 耿查看作者出版物


    您也可以在 PubMed Google Scholar 中搜索此作者


  7. Wafik s el-deiry查看作者出版物


    您也可以在 PubMed Google Scholar 中搜索此作者

 通讯作者


与 Wafik S el-Deiry 的通信。


开放获取本文根据 Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License 获得许可，该许可允许以任何媒体或格式进行任何非商业用途、共享、分发和复制，前提是您给予原作者和来源适当的署名，提供指向 Creative Commons 许可的链接，并说明您是否修改了许可材料。根据本许可，您无权共享源自本文或其部分的改编材料。本文中的图像或其他第三方材料包含在文章的知识共享许可中，除非在材料的致谢行中另有说明。如果材料未包含在文章的 Creative Commons 许可中，并且您的预期用途未被法律法规允许或超出允许的用途，您将需要直接从版权所有者处获得许可。要查看此许可证的副本，请访问 http://creativecommons.org/licenses/by-nc-nd/4.0/。

 重印本和权限

Check for updates. Verify currency and authenticity via CrossMark

 引用本文


Allen， JE， Krigsfeld， G.， Patel， L. 等人。更正：TRAIL 诱导化合物的鉴定突出了小分子 ONC201/TIC10 是一种激活 TRAIL 通路的独特抗癌剂。分子癌症23， 233 （2024）。https://doi.org/10.1186/s12943-024-02158-w

 下载引文


  • 发布日期：

 使用本文


您与之共享以下链接的任何人都可以阅读此内容：


抱歉，本文目前没有可共享链接。


由 Springer Nature SharedIt 内容共享计划提供
更新日期：2024-10-18
  点击分享   查看原文
点击收藏
公开下载
阅读更多本刊新发论文 本刊介绍/投稿指南
down
wechat
bug